On the site and mechanism of action of the anti-obesity effects of interleukin-6

被引:30
作者
Jansson, JO [1 ]
Wallenius, K
Wernstedt, I
Ohlsson, C
Dickson, SL
Wallenius, V
机构
[1] Sahlgrens Univ Hosp, Div Endocrinol, Gothenburg, Sweden
[2] Univ Cambridge, Dept Physiol, Cambridge, England
关键词
obesity; interleukin-6;
D O I
10.1016/S1096-6374(03)00051-0
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We conducted an experimental study examining the site and mechanism of action of the anti-obesity effect of interleukin-6 (IL-6) in mice and rats. We used dual energy X-ray absorptiometry (DEXA) and computerized tomography to investigate the body composition of mice with knockout of the IL-6 gene and wild-type control mice. Rats were treated with IL-6 or vehicle through intracerebroventricular (ICV) cannulae. Energy expenditure was measured as oxygen consumption by indirect calorimetry in metabolic chambers. Results showed that the mice lacking IL-6 increased in body weight compared with wild-type mice from 6 months of age onward, although there was no marked difference in food intake between the pre-obese IL-6 knockout mice and the wild-type mice. IL-6 given as a single ICV injection to rats stimulated oxygen consumption; whereas, the same doses were ineffective when given peripherally. Chronic ICV IL-6 treatment decreased body weight and fat mass in rodents. Administration of IL-6 may decrease fat mass in mice and rats by stimulating energy expenditure at the CNS level, possibly in the hypothalamus. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:S28 / S32
页数:5
相关论文
共 30 条
[1]   Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro [J].
Bastard, JP ;
Maachi, M ;
Van Nhieu, JT ;
Jardel, C ;
Bruckert, E ;
Grimaldi, A ;
Robert, JJ ;
Capeau, J ;
Hainque, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (05) :2084-2089
[2]   Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss [J].
Bastard, JP ;
Jardel, C ;
Bruckert, E ;
Blondy, P ;
Capeau, J ;
Laville, M ;
Vidal, H ;
Hainque, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (09) :3338-3342
[3]   Medicinal strategies in the treatment of obesity [J].
Bray, GA ;
Tartaglia, LA .
NATURE, 2000, 404 (6778) :672-677
[4]   Decreased cerebrospinal-fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance [J].
Caro, JF ;
Kolaczynski, JW ;
Nyce, MR ;
Ohannesian, JP ;
Opentanova, I ;
Goldman, WH ;
Lynn, RB ;
Zhang, PL ;
Sinha, MK ;
Considine, RV .
LANCET, 1996, 348 (9021) :159-161
[5]   Muscle-derived interleukin-6: mechanisms for activation and possible biological roles [J].
Febbraio, MA ;
Pedersen, BK .
FASEB JOURNAL, 2002, 16 (11) :1335-1347
[6]   Leptin and the regulation of body weight in mammals [J].
Friedman, JM ;
Halaas, JL .
NATURE, 1998, 395 (6704) :763-770
[7]   Expression of immunoregulatory cytokines in neurons of the lateral hypothalamic area and amygdaloid nuclear complex of rats immunized against human IgG [J].
Gao, Y ;
Ng, YK ;
Lin, JY ;
Ling, EA .
BRAIN RESEARCH, 2000, 859 (02) :364-368
[8]   Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance [J].
Gloaguen, I ;
Costa, P ;
Demartis, A ;
Lazzaro, D ;
DiMarco, A ;
Graziani, R ;
Paonessa, G ;
Chen, F ;
Rosenblum, CI ;
VanderPloeg, LHT ;
Cortese, R ;
Ciliberto, G ;
Laufer, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (12) :6456-6461
[9]  
Hirano T, 1998, Int Rev Immunol, V16, P249
[10]   Muscle contractions induce interleukin-6 mRNA production in rat skeletal muscles [J].
Jonsdottir, IH ;
Schjerling, P ;
Ostrowski, K ;
Asp, S ;
Richter, EA ;
Pedersen, BK .
JOURNAL OF PHYSIOLOGY-LONDON, 2000, 528 (01) :157-163